BIOMAT Database Logo BIOMAT Database Logo

Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated. 2004

V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Institute of Physico-Chemical Medicine, Malaya Pirogovskaya st., 1a, 119992, Moscow, Russia. nereshchagin@nm.ru

OBJECTIVE During a longitudinal study of the prevalence of antimicrobial resistance in Neisseria gonorrhoeae, a number of high-level fluoroquinolone-resistant isolates were obtained from the sexually transmitted diseases clinic in the Moscow region in 2002. The aim of the present study was to determine the molecular mechanisms of resistance and to assess the clonal relationship of these strains METHODS For the 32 clinical strains of N. gonorrhoeae studied, the MIC values were determined for four fluoroquinolones. The gyrA, parC, por and mtrR genes were studied for the presence of mutations associated with fluoroquinolone resistance. RESULTS We detected strains of N. gonorrhoeae showing high-level resistance to fluoroquinolones (21 strains, with MICs 1-32 mg/L). Mutations in gyrA and parC known to cause fluoroquinolone resistance were detected in a majority of strains. There were four strains (among 21) without known changes in gyrA and parC. However, amino acid changes in the Por protein and mutations in the promoter or encoding region of the mtrR gene were detected in three of them. One strain had no alteration in gyrA, parC, por or mtrR. CONCLUSIONS The present study documents the first case of fluoroquinolone-resistant N. gonorrhoeae in Russia.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
April 2019, BMC microbiology,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Molecular surveillance of clinical Neisseria gonorrhoeae isolates in Russia.
October 2010, Journal of clinical microbiology,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.
December 2011, Journal of clinical microbiology,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
December 2005, Diagnostic microbiology and infectious disease,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.
June 2005, Infectious disease clinics of North America,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
October 2000, Diagnostic microbiology and infectious disease,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
May 1998, MMWR. Morbidity and mortality weekly report,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004.
October 2006, Sexually transmitted diseases,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).
August 2016, BMC infectious diseases,
V A Vereshchagin, and E N Ilina, and M V Malakhova, and M M Zubkov, and S V Sidorenko, and A A Kubanova, and V M Govorun
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
February 2011, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!